Product References
Retinal ganglion cell-specific genetic regulation in primary open-angle glaucoma.
Cell genomics
Daniszewski M,Senabouth A,Liang HH,Han X,Lidgerwood GE,Hernández D,Sivakumaran P,Clarke JE,Lim SY,Lees JG,Rooney L,Gulluyan L,Souzeau E,Graham SL,Chan CL,Nguyen U,Farbehi N,Gnanasambandapillai V,McCloy RA,Clarke L,Kearns LS,Mackey DA,Craig JE,MacGregor S,Powell JE,Pébay A,Hewitt AW
MA1-023-PE was used in flow cytometry to assess the transcriptomic profile of disease-specific cell populations, fibroblasts from patients with primary open-angle glaucoma (POAG) were reprogrammed into induced pluripotent stem cells (iPSCs) before being differentiated into retinal organoids and compared with those from healthy individuals.
Wed Jun 08 00:00:00 EDT 2022
Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration.
Nature communications
Senabouth A,Daniszewski M,Lidgerwood GE,Liang HH,Hernández D,Mirzaei M,Keenan SN,Zhang R,Han X,Neavin D,Rooney L,Lopez Sanchez MIG,Gulluyan L,Paulo JA,Clarke L,Kearns LS,Gnanasambandapillai V,Chan CL,Nguyen U,Steinmann AM,McCloy RA,Farbehi N,Gupta VK,Mackey DA,Bylsma G,Verma N,MacGregor S,Watt MJ,Guymer RH,Powell JE,Hewitt AW,Pébay A
MA1-023-PE was used in Immunocytochemistry to uncover important differences in retinal pigment epithelium homeostasis associated with geographic atrophy.
Tue Jul 26 00:00:00 EDT 2022
Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I).
Stem cell research
Hernández D,Morgan Schlicht S,Daniszewski M,Karch CM,Goate AM,Pébay A
MA1-023-PE was used in Immunocytochemistry-immunoflourescence to report the genome-editing of an existing iPSC line carrying the London mutation in APP (V717I) into an iPSC line in which the pathogenic mutation was corrected.
Sat May 01 00:00:00 EDT 2021
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Stem cell research & therapy
Xu Y,Nasri M,Dannenmann B,Mir P,Zahabi A,Welte K,Morishima T,Skokowa J
MA1-023-PE was used in Flow Cytometry to the effects of specific inhibitors of Nicotinamide phosphoribosyltransferase (NAMPT) or nicotinamide adenine dinucleotide (NAD+)-dependent sirtuins (SIRTs) on the pluripotency, proliferation, survival, and hematopoietic differentiation of human iPS cells.
Fri Feb 05 00:00:00 EST 2021
NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells.
Stem cell research & therapy
Xu Y,Nasri M,Dannenmann B,Mir P,Zahabi A,Welte K,Morishima T,Skokowa J
MA1-023-PE was used in Flow Cytometry to the effects of specific inhibitors of Nicotinamide phosphoribosyltransferase (NAMPT) or nicotinamide adenine dinucleotide (NAD+)-dependent sirtuins (SIRTs) on the pluripotency, proliferation, survival, and hematopoietic differentiation of human iPS cells.
Fri Feb 05 00:00:00 EST 2021
Single cell eQTL analysis identifies cell type-specific genetic control of gene expression in fibroblasts and reprogrammed induced pluripotent stem cells.
Genome biology
Neavin D,Nguyen Q,Daniszewski MS,Liang HH,Chiu HS,Wee YK,Senabouth A,Lukowski SW,Crombie DE,Lidgerwood GE,Hernández D,Vickers JC,Cook AL,Palpant NJ,Pébay A,Hewitt AW,Powell JE
MA1-023-PE was used in microarray to demonstrate that the majority of eQTLs detected in fibroblasts are specific to an individual cell subtype.
Fri Mar 05 00:00:00 EST 2021
Quantification of Etoposide Hypersensitivity: A Sensitive, Functional Method for Assessing Pluripotent Stem Cell Quality.
Stem cells translational medicine
Secreto FJ,Li X,Smith AJ,Bruinsma ES,Perales-Clemente E,Oommen S,Hawse G,Hrstka SCL,Arendt BK,Brandt EB,Wigle DA,Nelson TJ
Published figure using TRA-1-60 monoclonal antibody (Product # MA1-023-PE) in Flow Cytometry
Sun Oct 01 00:00:00 EDT 2017